Program Overview

The burden of chronic obstructive pulmonary disease (COPD) on today’s healthcare landscape remains high, and addressing this burden requires increased vigilance of changing COPD symptoms and risk factors for exacerbations and hospitalizations. It also requires that specialty providers evaluate patient status and provide therapies matched to individual patient needs. This program aims to address gaps in healthcare provider ability to recognize individualized risk factors in patients with COPD, as well as improving collaboration between inpatient and outpatient providers.

Respiratory therapists are a steady presence during care for patients with COPD, and are ideally positioned to communicate with the hospital team, report findings from patient assessments, develop and modify COPD care plans, and consult with other departments involved in patient care. After hospital discharge and while patients are in the community, respiratory therapists can confirm patients have the appropriate long-term care and follow-up appointments and work with care coordinators and medical equipment providers involved in cases.

This program aims to address these gaps through novel education mechanisms and review strategies that have shown to be effective in reducing the burden imposed by COPD.

Target Audience

This educational initiative has been designed for respiratory therapists, internal medicine physicians, and other healthcare providers involved in the care of patients with COPD.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

Review the efficacy and safety of newer bronchodilator therapies and their combinations for patients with COPD

Select COPD medications and their devices based on the individualized needs of patients with COPD

Directions to Learner

There are no fees for participating and receiving CME credit for this enduring activity. During the period of November 7, 2017 through November 7, 2018, participants must:

Read the learning objectives and faculty disclosures

Complete the pretest

Study the educational activity

Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.

Media

Internet

American Association for Respiratory Care (AARC) Continuing Education

This program has been approved for a maximum of 1.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the AARC, 9425 N. MacArthur Blvd., Irving, TX 75063. Course #149900000.

Physician Continuing Medical Education Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Credit Designation

Integrity Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest (COI)

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Patima Tanapat, PhD, has no real or apparent conflicts of interest to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Sunovion Pharmaceuticals, Inc., do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc., and Sunovion Pharmaceuticals, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy Policy

When you participate in an online educational activity sponsored by Integrity CE, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and...(continued)

Disclaimer

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.